Also, mutant K-RAS may enhance β-catenin/TCF-dependent transcription in APC mutant K-RAS-dependent colon cancer cells by a mechanism involving bone morphogenetic protein (BMP)-7 secretion and autocrine signaling, leading to activation of TGF-β-activated kinase (TAK1) [19]. The gene discussed is KRAS; the disease is colonic neoplasm.